- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Coenzyme Q10 Pharmacokinetics in United States
Total 493 results
-
Eisai Inc.CompletedPharmacokinetics in Obese AdolescentsUnited States
-
Thomas Jefferson UniversityBristol-Myers SquibbCompletedHealthy | Venous Thromboembolism | PharmacokineticsUnited States
-
National Institute on Drug Abuse (NIDA)CompletedHealthy Volunteers | Pharmacokinetics | Nicotine DependenceUnited States
-
National Institute on Drug Abuse (NIDA)CompletedPharmacokinetics | Cannabis | Dependence | Cannabis Abuse | fMRIUnited States
-
MediGeneCompleted
-
International Partnership for Microbicides, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingBleeding | Pharmacokinetics | Safety IssuesUnited States
-
Mast Therapeutics, Inc.CompletedHealthy Volunteers | Renal Impaired | Pharmacokinetics of VepoloxamerUnited States
-
University of Maryland, BaltimoreCompletedRenal Insufficiency | Renal Failure | Acute Kidney Injury | PharmacokineticsUnited States
-
Imperial College LondonCompletedPharmacokinetics | Penicillin Allergy | Beta Lactam Adverse ReactionUnited Kingdom
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International LtdCompletedHealthy Volunteers | Pharmacokinetics of Isavuconazole | Renal ImpairedUnited States
-
Auburn UniversityTuscaloosa Veterans Affairs Medical CenterWithdrawnDepressive Disorder, Major | Pharmacogenetics | Medication Therapy ManagementUnited States
-
University of RochesterCompletedLow Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors | Moderate Risk (10-20% Chance) of Developing Cardiovascular (Heart) Disease Within 10 Years Based on Risk FactorsUnited States
-
Genelex CorporationCompletedDrug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome P450 CYP2C9 Enzyme Deficiency | Cytochrome P450 CYP2C19 Enzyme Deficiency | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | CYP2D6 Polymorphism | Ultrarapid... and other conditionsUnited States
-
AstraZenecaCompletedPharmacokinetics | Safety | Pharmacodynamics of AZD7594United Kingdom
-
University of CopenhagenCompleted
-
Clavis PharmaCompletedNot Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy SubjectsUnited Kingdom
-
Egalet LtdCompletedAssess Pharmacokinetics of Ketorolac Tromethamine Intranasal and Assess Effects of a Oxymetazoline Hydrochloride on the PK of Ketorolac TromethamineUnited Kingdom
-
AstraZenecaCompletedAsthma, | Pharmacokinetics, | Cmax, | Tmax, | λz, | AUC, | Ketoconazole, | MetaboliteUnited Kingdom
-
West Virginia UniversityCompletedHematological Malignancy | Pharmacokinetics of AcyclovirUnited States
-
AllerganCompletedOveractive Bladder | Pharmacokinetics | ElderlyUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedProstate Cancer | Pharmacokinetics of EnzalutamideUnited States
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid Arthritis | Pharmacokinetics of ASP2408United States
-
Amphastar Pharmaceuticals, Inc.CompletedAsthma | Pharmacokinetics | Anaphylaxis | Epinephrine | AlbuterolUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA); University of FloridaRecruitingKratom Withdrawal Symptoms | Kratom Pharmacokinetics | Kratom PharmacodynamicsUnited States
-
Children's Hospital Medical Center, CincinnatiActive, not recruitingCholestasis | Red Cell Membrane and Enzyme AbnormalitiesUnited States
-
University of California, MercedCompletedParents of Children Ages 10 to 17 Years OldUnited States
-
Emmaus Medical, Inc.CompletedSickle Cell Disease | PharmacokineticsUnited States
-
Sharon HillierNational Cancer Institute (NCI)CompletedCOVID-19 | Pharmacokinetics | SafetyUnited States
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA)CompletedSubstance Abuse | Methamphetamine | Pharmacogenetics | Methamphetamine Dependence | Amphetamine DependenceUnited States
-
AstraZenecaCompletedRheumatoid Arthritis | Healthy Volunteers | Pharmacokinetics | Drug-drug Interaction | Pioglitazone | Amount of Pioglitazone in BloodUnited States
-
Cwm Taf University Health Board (NHS)Unknown
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid Arthritis | Pharmacokinetics of ASP2409United States
-
Advocate Health CareCompletedDelirium, Cytochrome P-450 Enzyme SystemUnited States
-
Texas Tech University Health Sciences CenterUniversity of Texas Southwestern Medical Center; National Center for Research...CompletedObesity | Tuberculosis | Pharmacokinetics | MRSA | PCPUnited States
-
Washington University School of MedicineTerminatedAngioedema Caused by Angiotensin-Converting-Enzyme InhibitorUnited States
-
Astellas Pharma Global Development, Inc.CompletedRenal Impaired | Gilteritinib | Normal Renal Function | Pharmacokinetics of ASP2215United States, Bulgaria
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedPharmacokinetics | Pharmacodynamics | Drug-induced QT ProlongationUnited States
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedPharmacokinetics | Pharmacodynamics | Drug-induced QT ProlongationUnited States
-
Vanderbilt UniversityCompletedCoronary Artery Disease | Inflammation | Cardiopulmonary Bypass | Fibrinolysis | Angiotensin Receptor Blockers | Angiotensin Converting EnzymeUnited States
-
Astellas Pharma IncAgensys, Inc.CompletedRenal Cell Carcinoma | Pharmacokinetics of AGS-16M8FUnited States
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
Imperial College LondonRecruitingPharmacokinetics | Drug-Related Side Effects and Adverse Reactions | Infections, Bacterial | Drug MonitoringUnited Kingdom
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
University of Colorado, DenverBristol-Myers Squibb; The Miriam Hospital; University of WashingtonCompletedHIV Infections | Contraception | PharmacokineticsUnited States
-
Massimo Raimondo, M.D.Digestive Care, Inc.TerminatedPancreatic Cancer | Pancreatic Insufficiency | Pancreatic Enzyme AbnormalityUnited States
-
Teesside UniversityUniversity of SunderlandRecruitingFrontal Plane Projection Angle | Maximal Countermovement Jump | Repeated 10/5United Kingdom
-
University of FloridaCompletedVitamin D Deficiency (10 ng/mL to 30 ng/mL)United States
-
Cosmo Technologies LtdRecruitingAdvanced Refractory Solid Tumors | Subjects Considered Likely to Respond to CB-03-10United States
-
ShirePPDCompletedAngiotensin Converting Enzyme Inhibitor Induced AngioedemaUnited States, Canada, United Kingdom, Israel
-
University of PennsylvaniaCompletedPatients With Principal or Secondary Diagnosis Code of Intrntl Classification of Diseases, 9th Revision, (ICD-9-CM) 410 (Except When 5th Digit Was 2)United States